Key Takeaways
- Researchers have created viable, early-stage human embryos from skin cells for the first time.
- The process, dubbed “mitomeiosis,” transforms a skin cell’s nucleus into a functional egg, which can then be fertilized.
- While a significant step, all resulting embryos had chromosomal abnormalities, and the technique is at least a decade away from any clinical application.
- If perfected, this technology could offer new paths to parenthood for those facing infertility and for same-sex couples to have genetically related children.
Scientists at Oregon Health & Science University have achieved what was once thought to be impossible, creating viable human embryos from skin cells in a groundbreaking advance for reproductive medicine. The research, published in Nature Communications, details a new technique that could eventually offer hope to millions facing infertility, though clinical use remains a distant goal.
The innovative method, called “mitomeiosis,” involves transplanting the nucleus of a skin cell into a donor egg that has had its own genetic material removed. The researchers then coaxed this reconstructed egg to shed half of its chromosomes, turning it into a functional egg that could be fertilized with sperm. In the study, 9% of the resulting embryos developed to the blastocyst stage—the point where they would typically be transferred during IVF.
“We accomplished something that was thought to be impossible,” said Dr. Shoukhrat Mitalipov, who led the research at OHSU.
Despite the breakthrough, significant challenges lie ahead. All of the embryos created had chromosomal abnormalities that would prevent healthy development. However, the research opens up profound future possibilities. If the technique can be perfected, it could help women who have lost their eggs due to age or medical treatments. It also introduces the possibility for male same-sex couples to have children genetically related to both partners, by using one partner’s skin cells to create an egg and the other’s sperm for fertilization.
Reproductive medicine experts have praised the work as a crucial step forward but stress that extensive safety testing is required. The researchers estimate it will take at least another decade of research before the technology could even be considered for clinical trials.